NAD+ boosters can affect how certain medications like insulin, blood pressure lowering, antidepressants, and cancer ...
The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients ...
Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent ...
4d
MedPage Today on MSNMyasthenia Gravis ExacerbationsGeneralized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction ...
Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profileof VYVGART and VYVGART HytrulogMG patients on VYVGART ...
AdBlock Plus is probably the most popular ad-blocking extension for Chrome, if only because it’s the first one that pops up when you search for blockers on the Chrome Web Store extension repository.
18d
MedPage Today on MSNDelays in Diagnosing Generalized Myasthenia GravisHeightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement inhibitors and ...
Decreased AChR-Ab titers correlated with improved myasthenia gravis symptoms, especially in ADL scores, within the first 3 months of treatment. The study found no baseline correlation between AChR ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor ...
A schools inspector in Ntungamo District has sounded the alarm over the moral degeneration of school-going youths, blaming parents for being too lenient and failing to understand the changing ...
Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis ... in ...
There is a "toxic discourse" within politics and the media around the issue of puberty blockers, the agriculture minister has said. Andrew Muir said he was "really concerned" about the impact of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results